Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-022736-37Phase 3Completed
Phase 3, randomised trial in post-traumatic pain, sprain, muscle strain and 1 more comparing Z7202 once daily with Flector twice daily (2 arms). Primary endpoint: Change in spontaneous pain intensity at rest from baseline to day 5. Started Oct 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-022736-37.